As from May 15, 2024, Elicera Therapeutics AB (publ) will change Certified Adviser to Mangold Fondkommission AB. This information is distributed at the request of the Certified Adviser, Carnegie Investment Bank AB. For further information, please call Carnegie Investment Bank AB on +46 (8) 5886 86 63.
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.02. | Elicera Therapeutics receives partial payment of 0,5 MEur from EIC | ||
| 12.02. | Elicera Therapeutics Receives Notification of Partial Payment of EUR 500,000 from the European Innovation Council Accelerator Programme | ||
| 10.02. | Elicera Therapeutics Presents Initial Clinical Data from the CARMA Study at ISCT 2025 in New Orleans | ||
| 05.02. | ELICERA THERAPEUTICS: Elicera's CEO: "2025 is a crucial year for us" | ||
| 03.02. | Elicera Therapeutics AB: Elicera Therapeutics AB (publ) Year-end Report 1 January - 31 December 2024 | Fourth quarter (October-December 2024)
Operating profit/loss amounted to SEK -2,911,958 (-5,212,694).
Loss for the period amounted to SEK -2,603,242 (-4,749,222).
Cash flow from operating activities... ► Artikel lesen |
